- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05507788
Multicell Air Cushions: Sitting Posture and Limits of Stability
August 17, 2022 updated by: David Rusaw, Jonkoping University
Wheelchair Seating: An Assessment of Multicell Air Cushions on Sitting Posture and Limits of Stability
The study's aim is to assess the sitting and dynamic postural control of stability of wheelchair users who have compromised postural control and risk of ulcers while using individually adjusted multi-cell air cushions with and without individual cell-locking function and variable depths.
Study Overview
Status
Enrolling by invitation
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
15
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Jönköping, Sweden, 55111
- Jonkoping University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- individuals who use a wheelchair
- have used a wheelchair for no less than 2 years
- score from 3-6 on the Functional Independence Measure
- not currently inpatients or those currently accessing acute care for concomitant health-related issues
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Cushion
Three seating conditons (Quadtro Select 10cm, Starlock 10cm, and Starlock 13cm)
|
Reaching tasks during each of the seating conditions decribed in the Arms section.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Reach distance
Time Frame: Day 1
|
the linear distance from the start position to the furthest reach point during the trial
|
Day 1
|
|
Accuracy
Time Frame: Day 1
|
the ratio of the minimum distance (straight line) from the start position to the total distance traveled until the furthest reach point
|
Day 1
|
|
Time
Time Frame: Day 1
|
length of time from the start position to furthest reached point
|
Day 1
|
|
total path length of Center of Pressure
Time Frame: Day 1
|
Day 1
|
|
|
mean velocity of Center of Pressure
Time Frame: Day 1
|
Day 1
|
|
|
pressure-distribution between the seating surface and the two foot Force-sensing arrays
Time Frame: Day 1
|
Day 1
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: David F Rusaw, PhD, Jonkoping University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 30, 2022
Primary Completion (Anticipated)
October 30, 2022
Study Completion (Anticipated)
December 30, 2022
Study Registration Dates
First Submitted
April 28, 2022
First Submitted That Met QC Criteria
August 17, 2022
First Posted (Actual)
August 19, 2022
Study Record Updates
Last Update Posted (Actual)
August 19, 2022
Last Update Submitted That Met QC Criteria
August 17, 2022
Last Verified
August 1, 2022
More Information
Terms related to this study
Other Study ID Numbers
- ETAC
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Wheelchairs
-
Laval UniversityActive, not recruiting
-
Nova Scotia Health AuthoritySuspended
-
Nova Scotia Health AuthorityDalhousie UniversityCompleted
-
Nova Scotia Health AuthorityWithdrawn
-
University of AlbertaPermobil, Inc.Completed
-
VA Office of Research and DevelopmentCompletedUse of Power Wheelchairs and Power Seat FunctionsUnited States
-
University of South CarolinaFoundation for Physical Therapy, Inc.CompletedPeople Who Use Motorized Wheelchairs for MobilityUnited States
-
Centre Hospitalier Universitaire de NīmesCompletedMobility Limitation | Wheelchairs
-
Lee KirbyCompletedHemiplegia | WheelchairsCanada
-
Swiss Paraplegic Centre NottwilCompletedWheelchairs | Dietary Supplements | Heart Rate/Drug Effects | Lactic Acid/Metabolism | Physical Education and Training/MethodsSwitzerland
Clinical Trials on Wheelchair air cushion
-
University of MichiganJRD Enterprises LLC; Michigan Corporate Relations Network Small Company Innovation...CompletedStroke | Spinal Cord Injuries | Healthy AdultsUnited States
-
University of PittsburghEunice Kennedy Shriver National Institute of Child Health and Human Development...Completed
-
University of PittsburghEunice Kennedy Shriver National Institute of Child Health and Human Development...Completed
-
KalogonUnited States Department of Defense; EC ServiceCompleted
-
Seoul National University HospitalCompletedChronic Allograft NephropathyKorea, Republic of
-
Cancer Institute and Hospital, Chinese Academy...Completed
-
University of KansasSusan G. Komen Breast Cancer FoundationCompleted
-
VA Office of Research and DevelopmentCompletedSpinal Cord Injuries and DisordersUnited States
-
Reckitt Benckiser Healthcare (UK) LimitedO4 ResearchCompleted
-
The First Hospital of QinhuangdaoCompletedTherapeutic Procedural ComplicationChina